Joint Formulary & PAD

Beclometasone with formoterol (Fostair) - Chronic Obstructive Pulmonary Disease (COPD)

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

PAD Profile

ChemicalSubstance :
Beclometasone with formoterol (Fostair)
Indication :
Chronic Obstructive Pulmonary Disease (COPD)
Group Name :
ICS LABA
Keywords :
ICS/LABAs, ICS LABAs, Respiratory, inhaled corticosteroids
Brand Names Include :
Fostair
Important Information :

In new patients - Only for those who have had a trial of Proxor and where the specialist team consider that a trial of Fostair pMDI would be beneficial.

Proxor device is the preferred beclometasone with formoterol pMDI.

Latest Additions Date From :
Latest Additions Date To :
Supporting Documents :
7

Committee Recommendations (0)

  • No records returned.

Other Indications

Below are listed other indications that Beclometasone with formoterol (Fostair) is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Chronic Obstructive Pulmonary Disease (COPD).